Discover 3,059 paid clinical trials in Pennsylvania. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Pennsylvania provides numerous options to healthy volunteers looking to take part in paid research studies, as well as participants looking for condition-specific trials. Research hubs in Philadelphia, Pittsburgh, and Allentown are actively recruiting participants, giving access to groundbreaking treatments and quality healthcare.
Filter
1
Filter results
Results: 3,059
Active & Responsive
Tai Chi for Reducing Aromatase Inhibitor-Induced Arthralgia
for
Hormone Receptor Positive Breast Carcinoma, Postmenopausal,
Location: Philadelphia PA
Sponsor: Thomas Jefferson University
Sex: Female
Age: 18+
Code: NCT07737951
Recruiting
Active & Responsive
Dorzagliatin in Pancreatic Insufficient Cystic Fibrosis
FORWARD: Functional Outcomes in Real-World Treatment And Revascularization of Non-dominant and Distal M2 Occlusions
for
Acute Ischemic Stroke,
Location: New Haven CT, Stony Brook NY, Manhasset NY, York PA,
Sponsor: Penumbra Inc.
Sex: All
Age: 18+
Code: NCT07749170
Recruiting
Active & Responsive
Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol Secretion
for
Mild Autonomous Cortisol Secretion (MACS),
Location: Pittsburgh PA
Sponsor: Alaa Sada
Sex: All
Age: 18+
Code: NCT07573163
Phase 2, Recruiting
Active & Responsive
A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease
for
Danon Disease
Location: Boston MA, Philadelphia PA, La Jolla CA
Sponsor: Rocket Pharmaceuticals Inc.
Sex: Male
Age: 8+
Code: NCT06092034
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)
for
REM Sleep Behavior Disorder
Location: Boston MA, North Haven CT, New York NY, Philadelphia PA,
Sponsor: Yale University
Sex: All
Age: 50 - 70+
Code: NCT06996652
Phase 2, Recruiting
Active & Responsive
Ruxolitinib in Previously Treated Idiopathic Multicentric Castleman Disease
for
Castleman's Disease (CD),
Location: Philadelphia PA
Sponsor: University of Pennsylvania
Sex: All
Age: 18 - 70+
Code: NCT07085039
Phase 2, Recruiting
Active & Responsive
A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer
for
Non Small Cell Lung Cancer
Location: New York NY, Philadelphia PA, Coral Gables FL,
Sponsor: Ankyra Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT07027514
Phase 1, Recruiting
Active & Responsive
Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
for
Idiopathic Pulmonary Fibrosis (IPF)
Location: North Dartmouth MA, Hialeah FL, DuBois PA,
Sponsor: PureTech
Sex: All
Age: 40+
Code: NCT07284602
Phase 3, Recruiting
Active & Responsive
9-ING-41 Combined With Retifanlimab, Plus Modified FOLFIRINOX for Patients With Advanced Pancreatic Adenocarcinoma (RiLEY)
for
Pancreatic Adenocarcinoma
Location: Pittsburgh PA
Sponsor: Anwaar Saeed
Sex: All
Age: 18+
Code: NCT06896188
Phase 1, Recruiting
Active & Responsive
Bacteriophages for Adults With Cystic Fibrosis and Chronic Achromobacter Lung Infection
for
Cystic Fibrosis (CF), Achromobacter Infection
Location: Pittsburgh PA
Sponsor: Ghady Haidar
Sex: All
Age: 18+
Code: NCT07275905
Phase 1, Recruiting
Active & Responsive
STEPS - Stress Training and Engagement Via Phone-Based Systems
for
Psychological Distress, Mindfulness Skills,
Location: Pittsburgh PA
Sponsor: Equa Health
Sex: All
Age: 18 - 30
Code: NCT07639697
Recruiting
Active & Responsive
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
for
Extensive Stage Lung Small Cell Carcinoma,
Location: North Haven CT, New Haven CT, Trumbull CT, New York NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06287775
Phase 1, Phase 2, Recruiting
Active & Responsive
Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease